Shreeram Aradhye serves as Executive at Dicerna Pharmaceuticals Inc, where they oversee executive responsibilities. Since joining the company, Shreeram Aradhye has executed 5 insider transactions totaling $44.1K, demonstrating a bearish approach to their equity position. Their most recent transaction on Dec 28, 2021 involved transacting 6,973 shares valued at $266.7K.
Shreeram Aradhye currently holds 7,806 shares of Dicerna Pharmaceuticals Inc (DRNA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Shreeram Aradhye has been a net seller of DRNA stock. They have purchased $0 and sold $44.1K worth of shares.
Shreeram Aradhye's most recent insider trade was on Dec 28, 2021, when they sold 6,973 shares at $38.25 per share.
Get notified when new Form 4 filings are submitted
| 2,837 |
| $N/A |
| Discretionary |
| Dec 15, 2021 | DRNA | $31.7K | Payment | 833 | $38.05 | Discretionary |
| Sep 17, 2021 | DRNA | $44.1K | Sale | 2,056 | $21.47 | Discretionary |
| Sep 15, 2021 | DRNA | $0 | Option Exercise | 7,025 | $N/A | Discretionary |